In her first interview since becoming the Democratic nominee, Vice President Kamala Harris told CNN’s Dana Bash that her “values have not changed,” even though when she ran for the nomination in 2019, she said she was in favor of a ban. Fracking, of course, is a lightning rod issue in the critical swing state of Pennsylvania.
According to Astrobotic’s post-mission report:
After an extensive review of the events before, during, and after Peregrine’s mission, the board concluded that the most likely cause of Peregrine’s anomaly was the failure of a singular helium pressure control valve, called PCV2, within the propulsion system.
The Elon Musk-led company is allegedly running gas turbines without the proper permit at a data center in Memphis, TN. Local environmental groups are reportedly urging regulators to investigate.
They’re worried about nitrogen oxides (NOx), smog-forming pollution that can aggravate respiratory illness.
In which a scientific feud gets surprisingly personal:
When During looks at a bone, she sees a chemical matrix waiting to be investigated. She sees an opportunity to extract information. When DePalma looks at a bone, he sees a narrative. He tells stories about the bones, some of them true.
[Intelligencer]
The South Dublin County Council rejected the proposal, Bloomberg reports. Google reportedly didn’t provide sufficient information about “how the proposal will impact the power supply once operational.”
New data centers being built with the boom in AI have raised concerns about straining the power grid. Ireland is a hot spot for that construction, where data centers already use more electricity than urban households.
The US Department of Health and Human Services will be offering four free home Covid tests to each household at the end of September. This, together with the roll-out of the latest vaccines (I’ve already made my appointment), is another sign that the coronavirus has made a strong reappearance this summer.
[aspr.hhs.gov]
The Dexcom Stelo aims to help people with Type 2 diabetes access CGMs more affordably.
